A detailed history of Creative Planning transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Creative Planning holds 19,307 shares of PLSE stock, worth $278,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,307
Previous 18,971 1.77%
Holding current value
$278,020
Previous $286,000 18.88%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$14.52 - $18.52 $4,878 - $6,222
336 Added 1.77%
19,307 $340,000
Q2 2025

Aug 08, 2025

BUY
$14.48 - $19.27 $57,210 - $76,135
3,951 Added 26.3%
18,971 $286,000
Q1 2025

May 15, 2025

SELL
$15.61 - $24.56 $15,766 - $24,805
-1,010 Reduced 6.3%
15,020 $241,000
Q4 2024

Feb 14, 2025

SELL
$14.56 - $21.08 $85,612 - $123,950
-5,880 Reduced 26.84%
16,030 $296,000
Q3 2024

Oct 11, 2024

BUY
$10.83 - $21.83 $126,353 - $254,690
11,667 Added 113.9%
21,910 $384,000
Q2 2024

Aug 15, 2024

BUY
$6.69 - $14.54 $68,525 - $148,933
10,243 New
10,243 $114,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $535M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.